×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Part 4: Planning for Recovery: How Research Sponsors and Research Sites are Thinking Ahead to Restart Research

May 14, 2020
Our panel of experts discuss what you need to know about the impact of COVID-19 on your clinical trials:
  • What are sponsors doing now to plan ahead and to position studies to return to full activity as precautions release?
  • How can sites prepare for the wave of study restarts? What can be done now- even remotely- to maintain contact with participants, sponsors and vendors?
  • What will be different about our research studies, procedures and practices as we move into a post-COVID world?
Previous Flipbook
Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes
Part 5: Maintaining Data Collection and Data Validity Amidst Major Study Changes

Next Flipbook
Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions
Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions

Request a Genetics in Clinical Trials training session

What You'll Learn